你好,请登录   免费注册    |    收藏本站
联系电话: 0574-87917803
联系电话: call_new 0574-87917803
HAA1
HAA1
规格:
货期:
编号:TS212076
品牌:Testobio
产品名称: HAA1
商品货号: TS212076
Organism: human (B cell); human (myeloma)
Cell Type: hybridoma: B lymphocyte
Product Format: frozen
Morphology: lymphoblast
Culture Properties: suspension
Biosafety Level: 2

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Disclosure: This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC.
Derivation:
Splenic B cells from a patient were fused with LTR228 lymphoblastoid cells.
Clinical Data:
Splenic B cells from a patient were fused with LTR228 lymphoblastoid cells.
Genes Expressed:
immunoglobulin; monoclonal antibody; against Blood group A antigen
Cellular Products:
immunoglobulin; monoclonal antibody; against Blood group A antigen
Comments:
Splenic B cells from a patient were fused with LTR228 lymphoblastoid cells.
Complete Growth Medium: Iscoves modified Dulbeccos medium, 85%; fetal bovine serum, 15%
Subculturing:
Medium Renewal: Every 2 to 3 days
Cultures can be maintained by addition or replacement of fresh medium. Start cultures at 2 X 10 exp5 cells/ml and maintain between 1 X 10 exp5 and 1 X 10 exp6 cells/ml.
Cryopreservation:
fetal bovine serum, 95%; DMSO, 5%
Name of Depositor: Cetus Corp.
Deposited As: human (B cell); human (myeloma)
U.S. Patent Number:
References:

Raubitschek AR, et al. Human lymphoblastoid cell line and hybridomas derived therefrom. US Patent 4,624,921 dated Nov 25 1986

首页 > 产品中心 > 微生物培养 > 菌株 > null > HAA1

HAA1

  • 货号: TS212076
  • 好评
询价
  • 品牌 : TESTOBIO
产品名称: HAA1
商品货号: TS212076
Organism: human (B cell); human (myeloma)
Cell Type: hybridoma: B lymphocyte
Product Format: frozen
Morphology: lymphoblast
Culture Properties: suspension
Biosafety Level: 2

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Disclosure: This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC.
Derivation:
Splenic B cells from a patient were fused with LTR228 lymphoblastoid cells.
Clinical Data:
Splenic B cells from a patient were fused with LTR228 lymphoblastoid cells.
Genes Expressed:
immunoglobulin; monoclonal antibody; against Blood group A antigen
Cellular Products:
immunoglobulin; monoclonal antibody; against Blood group A antigen
Comments:
Splenic B cells from a patient were fused with LTR228 lymphoblastoid cells.
Complete Growth Medium: Iscoves modified Dulbeccos medium, 85%; fetal bovine serum, 15%
Subculturing:
Medium Renewal: Every 2 to 3 days
Cultures can be maintained by addition or replacement of fresh medium. Start cultures at 2 X 10 exp5 cells/ml and maintain between 1 X 10 exp5 and 1 X 10 exp6 cells/ml.
Cryopreservation:
fetal bovine serum, 95%; DMSO, 5%
Name of Depositor: Cetus Corp.
Deposited As: human (B cell); human (myeloma)
U.S. Patent Number:
References:

Raubitschek AR, et al. Human lymphoblastoid cell line and hybridomas derived therefrom. US Patent 4,624,921 dated Nov 25 1986

合作单位: